14 unknown, 5 completed, 2 recruiting, 1 active not recruiting. 10 Phase 2, 6 Phase 3, 4 Phase 1, 3 Phase 4, 1 Not applicable.
Follow Simcere Pharmaceutical Co., Ltd: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Crossover Study to Evaluate the Relative Bioavailability of Two Formulations of Deuterated Remdesivir Hydrobromide for Oral Suspension in Healthy Chinese Adults T-R (Test-Reference drug), R-T (Reference-Test drug) - Healthy Participants | Phase 1 | Completed | Simcere Pharmaceutical Co., Ltd | 48 | 2026-04-17 | 2026-10-23 |
| A Multicenter Phase 2a Clinical Study to Evaluate SIM0278 in Subjects With Active Lupus Nephritis SIM0278 injection - Lupus Nephritis | Phase 2 | Not yet recruiting | Simcere Pharmaceutical Co., Ltd | 60 | 2026-03-31 | 2026-02-06 |
| A Phase III Study of Deuremidevir Hydrobromide for the Treatment of RSV Infection in Infants and Young Children SIM0916, SIM0916 Placebo - Respiratory Syncytial Virus Infection | Phase 3 | Recruiting | Simcere Pharmaceutical Co., Ltd | 498 | 2026-03-11 | 2026-04-02 |
| A Comparative Study of the Pharmacokinetics of SIM0718 Injection in Healthy Adult Subjects in China Rademikibart injection, CBP-201 injection - Healthy Adult Subjects | Phase 1 | Completed | Simcere Pharmaceutical Co., Ltd | 178 | 2024-11-28 | 2026-04-03 |
| A Study to Evaluate the Efficacy and Safety of SIM0718 in Adult and Adolescent Patients With Moderate to Severe Atopic Dermatitis SIM0718 Injection - Atopic Dermatitis | Phase 3 | Completed | Simcere Pharmaceutical Co., Ltd | 259 | 2024-07-04 | 2026-03-31 |
| SIM0718 Treatment of Asthma Clinical Study SIM0718 injection, SIM0718 injection of placebo - Asthma; Eosinophilic | Phase 3 | Active not recruiting | Simcere Pharmaceutical Co., Ltd | 418 | 2024-06-23 | 2026-10-21 |
| Edaravone Dexborneol Sublingual Tablet for the PSCI in Acute Ischemic Stroke Patients Edaravone dexborneol sublingual tablet, Placebo - Post-stroke Cognitive Impairment | Phase 2 | Recruiting | Simcere Pharmaceutical Co., Ltd | 226 | 2024-04-08 | 2025-09-03 |
| The Efficacy and Safety of Edaravone Dexborneol Sequential Therapy in the Treatment of Patients With AIS Edaravone Dexborneol Sequential Therapy, Placebo - Subjects With Acute Ischemic Stroke | Phase 3 | Unknown | Simcere Pharmaceutical Co., Ltd | 880 | 2023-12-28 | 2023-12-20 |
| A Study to Evaluate the Pharmacokinetics,Safety and Tolerability of Y-2 Sublingual Tablet in Healthy Adult Subjects Y-2 Sublingual Tablet, Placebo - Healthy | Phase 1 | Completed | Simcere Pharmaceutical Co., Ltd | 36 | 2023-09-06 | 2023-12-12 |
| Evaluate the Efficacy and Safety of Different Doses of Edaravone Dexborneol Concentrated Solution for Injection Combined With Conventional Medical Therapy in the Treatment of Patients With Cerebral Hemorrhage Sanbexin IV/Placebo - Subjects With Cerebral Hemorrhage | Phase 2 | Terminated | Simcere Pharmaceutical Co., Ltd | 80 | 2023-07-03 | 2026-04-06 |
| Nocardia Rubra Cell Wall Skeleton (N-CWS) Plus HAIC, Lenvatinib and Tislelizumab in Treating Patients With Advanced HCC Nocardia rubra cell wall skeleton, Hepatic arterial infusion chemotherapy, Lenvatinib - Hepatocellular Carcinoma | Phase 1 | Unknown | Wan-Guang Zhang | 30 | 2022-09-01 | 2023-12-19 |
| Application of Two Anti-angiogenesis Drugs Combined With Chemotherapy in Advanced Colorectal Cancer Under the Background of Precision Medical Two Anti-angiogenesis Drugs（Endostar and Thalidomide）, Pure chemotherapy（Xelox） - Colorectal Neoplasms | Phase 3 | Unknown | The First People's Hospital of Hefei | 148 | 2016-01-01 | 2016-04-22 |
| Radiation Dose Study of Concurrent Chemoradiotherapy With Cisplatin Plus Fluorouracil in Oesophageal Cancer Megavoltage photon beam, cisplatin-fluorouracil chemotherapy - Esophageal Neoplasms | Not applicable | Unknown | Simcere Pharmaceutical Co., Ltd | 500 | 2012-08-01 | 2012-07-20 |
| The Use of CT Perfusion to Determine the Normalization Window Period in the Treatment of Advanced Primary Lung Adenocarcinoma With Endostar endostar - Advanced Primary Lung Adenocarcinoma | Phase 2 | Unknown | Simcere Pharmaceutical Co., Ltd | 20 | 2012-03-01 | 2012-03-27 |
| Efficacy and Safety Study of Recombinant Endostatin Combined With Chemotherapy to Treat Advanced Colorectal Cancer Endostatins (Endostar), Oxaliplatin, Leucovorin - Colorectal Cancer | Phase 2 | Unknown | Chinese Academy of Medical Sciences | 51 | 2011-10-01 | 2013-11-27 |
| Trial of Endostar Combined With CHOPT for T Cell Lymphoma Endostar and CHOPT - T Cell Lymphoma | Phase 2 | Unknown | Tianjin Medical University Cancer Institute and Hospital | 30 | 2011-06-01 | 2015-11-04 |
| Study of Concurrent Chemo-radiotherapy Combined With Recombinant Human Endostatin for Local Advanced Non-small Cell Lung Cancer (NSCLC) radiotherapy combined with EP, radiotherapy / EP combined with recombinant human endostatin - Non-small Cell Lung Cancer | Phase 4 | Unknown | Simcere Pharmaceutical Co., Ltd | 170 | 2010-10-01 | 2010-09-29 |
| A Randomized, Open, Prospective Clinical Research of Fluorouracil Implant to Improve Surgical Gallbladder Cancer and Bile Duct Cancer Fluorouracil implant - Gallbladder Cancer, Bile Duct Cancer | Phase 2 | Unknown | Simcere Pharmaceutical Co., Ltd | 100 | 2010-06-01 | 2011-03-17 |
| A Study of Endostar Combined With Chemotherapy Followed by Endostar Maintenance Therapy to Treat Advanced Non-small Cell Lung Cancer (NSCLC) Endostar, Gemcitabine-Cisplatin chemotherapy - Non-small Cell Lung Cancer (NSCLC) | Phase 4 | Unknown | Simcere Pharmaceutical Co., Ltd | 120 | 2009-09-01 | 2009-12-09 |
| The Effect of Fluorouracil Implants Regional Chemotherapy During the Surgical Treatment for Early Stage Hepatocellular Carcinoma Radical resection, Fluorouracil Implants - Early Stage Hepatocellular Carcinoma | Phase 2 | Unknown | Simcere Pharmaceutical Co., Ltd | 250 | 2009-08-01 | 2010-01-26 |
Showing 20 of 24. Sign in to see all of them.
Carcinoma, Non-Small-Cell Lung (4) · Colorectal Neoplasms (3) · Carcinoma, Hepatocellular (2) · Bile Duct Neoplasms (1) · Dermatitis, Atopic (1) · Esophageal Neoplasms (1) · Gallbladder Neoplasms (1) · Lupus Nephritis (1) · Lymphoma, T-Cell (1) · Pulmonary Eosinophilia (1) · Respiratory Syncytial Virus Infections (1)
endostar protein (7) · Endostatins (6) · Fluorouracil (3) · Control Groups (2) · Dacarbazine (1) · Docetaxel (1) · Folfox protocol (1) · Leucovorin (1) · Oxaliplatin (1) · Radiotherapy (1) · Thalidomide (1) · cell wall skeleton, Nocardia (1) · lenvatinib (1) · tislelizumab (1)
China (22) · United States (1)
Cheng Zhou (1) · David Han, MD (1) · Guo Jun, PI (1) · Jianzhong Zhang (1) · Kai LI, professor (1) · Liao Meilin, M.D. (1) · Lin Yang, MD (1) · Shuqun Cheng, MD (1) · Wan-guang Zhang, M.D. (1) · Xiaonan Yao (1) · Xinchen Sun, M.D.,Ph.D. (1) · Yang Ling, M.D, Ph.D (1)